CAH — Cardinal Health, Inc. stock price, charts and financials

QT61Cardinal Health, Inc.

Cardinal Health, Inc. (NYSE: CAH) is a Healthcare company in the Medical - Distribution industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
236.31
-0.09-0.04%
CAHQT61Cardinal Health, Inc.·NYSE
236.31-0.04%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E36.04EPS (ttm)6.56Insider Own1.08%Shs Outstand234.21MPerf Week2.77%
Market Cap55.37BForward P/E17.40EPS next Y13.59Insider Trans-0.20%Shs Float233.73MPerf Month1.13%
Enterprise Value60.35BPEG17.82EPS next Q-Inst Own-Short Float2.89%Perf Quarter27.59%
Income1.56BP/S0.22EPS this Y84.65%Inst Trans-Short Ratio2.85Perf Half Y4.06%
Sales250.50BP/B-EPS next Y12.50%ROA2.75%Short Interest6.75MPerf YTD15.04%
Book/sh-P/C11.09EPS next 5Y13.62%ROE-55.72%52W High244.78 -3.46%Perf Year50.96%
Cash/sh-P/FCF12.61EPS past 3/5Y-ROIC11.62%52W Low137.70 71.62%Perf 3Y153.95%
Dividend Est.2.06 (0.87%)EV/EBITDA19.94Sales past 3/5Y7.07% 7.80%Gross Margin3.68%Volatility2.52% 2.17%Perf 5Y298.11%
Dividend TTM2.05 (0.87%)EV/Sales0.24EPS Y/Y TTM89.57%Oper. Margin0.92%ATR (14)5.52Perf 10Y186.34%
Dividend Ex-DateJul 01, 2026Quick Ratio0.48Sales Y/Y TTM10.46%Profit Margin0.62%RSI (14)57.96Recom2.45
Dividend Gr. 3/5Y0.91% 0.95%Current Ratio0.91EPS Q/Q64.25%SMA202.70%Beta0.52Target Price258.50
Payout31.49%Debt/Eq-Sales Q/Q11.05%SMA504.92%Rel Volume0.66Prev Close236.40
Employees57,700LT Debt/Eq-3.28EarningsAug 11SMA20012.19%Avg Volume2.34MPrice236.31
IPO DateAug 04, 1983Option/ShortYes / YesEPS/Sales Surpr.13.43% -1.87%Net Debt/EBITDA1.65Volume1,546,255Change-0.04%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-20-26ReiteratedUBSBuy$260$274
May-01-26ReiteratedRobert W. Baird$257$248
Apr-08-26ReiteratedEvercore ISI GroupOutperform$260$240
Mar-09-26ReiteratedLeerink PartnersOutperform$240$275
Feb-24-26ReiteratedBarclaysOverweight$243$258
Feb-10-26ReiteratedWells FargoOverweight$179$256
Feb-06-26ReiteratedMorgan StanleyOverweight$245$255
Feb-06-26ReiteratedRobert W. Baird$250$252
Feb-06-26ReiteratedUBSBuy$250$260
Feb-06-26ReiteratedMizuhoOutperform$222$235
Latest News
Aug-07-26
Aug-06-26
Aug-04-26
Aug-03-26
Jul-30-26
Jul-29-26
Jul-28-26
Jul-22-26
Company

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
6/30/2025
FY 2024
6/30/2024
FY 2023
6/30/2023
FY 2022
6/30/2022
FY 2021
6/30/2021
FY 2020
6/30/2020
FY 2019
6/30/2019
FY 2018
6/30/2018
Total Revenue250,549222,578226,827
Cost of Goods Sold Incl. D&A241,319214,410219,413
Gross Profit9,2308,1687,414
Selling, General and Administrative Excl. Other5,9915,3825,000
Research and Development
000
Other Operating Expense9275111,171
Operating Income2,3122,2751,243
Interest Expense34321551
Unusual Expense
Non-Operating Income (Expense)35419
Net Income Before Taxes2,0042,1011,201
Income Taxes456532348
Consolidated Net Income1,5591,561852
Net Income From Continuing Operations1,5481,569853
Net Income1,5591,561852
EPS (Recurring)6.566.483.48
EPS (Basic, Before Extraordinaries)6.566.483.48
EPS (Diluted)6.546.453.45
EBITDA3,0263,1061,962
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio36.1326.0528.50
Price To Sales Ratio0.220.180.11
Gross Margin3.683.673.27
Operating Margin0.921.020.55
Net Margin0.620.700.38
Shares Outstanding235241245
Market Capitalization55,53440,48824,088
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$253.76$223.32$192.88$162.43$131.99 Close Price0.00M12.72M25.44M38.16M50.88MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Greene Michelle D.Chief Information OfficerFeb 27 '26Sale228.472,746627,38712,230Mar 03
Alt Aaron EChief Financial OfficerFeb 18 '26Sale225.502,328524,96426,408Feb 18
Hall Patricia HemingwayDirectorFeb 06 '26Sale229.724,000918,88028,264Feb 10
WEITZMAN DEBORAHCEO, PSS SegmentAug 20 '25Sale150.5321,3673,216,37553,428Aug 20
Hollar Jason M.Chief Executive OfficerAug 20 '25Sale150.0435,9015,386,567200,000Aug 20
Hollar Jason M.Chief Executive OfficerAug 19 '25Sale148.90107,70516,037,649235,901Aug 19
Snow Ola MChief Human Resources OfficerAug 19 '25Sale148.9428,1514,192,91715,431Aug 19
Scherer Mary C.Chief Accounting OfficerAug 19 '25Sale149.256,7661,009,8263,556Aug 19
Alt Aaron EChief Financial OfficerAug 19 '25Sale148.7848,2437,177,39030,650Aug 19
Greene Michelle D.Chief Information OfficerAug 19 '25Sale148.8213,5002,009,04314,976Aug 19
Mayer Jessica LChief Legal/Compliance OfficerAug 19 '25Sale148.8238,0785,666,83348,457Aug 19
Mason Stephen MCEO, GMPD SegmentAug 19 '25Sale148.8241,5756,187,06326,085Aug 19
Scherer Mary C.Chief Accounting OfficerNov 14 '24Sale123.553,504432,9198,752Nov 14
Mayer Jessica LChief Legal/Compliance OfficerAug 21 '24Sale109.3916,5731,812,92075,971Aug 22
Greene Michelle D.Chief Information OfficerAug 19 '24Sale108.854,000435,40019,242Aug 19
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.